Who is sponsoring NCT03339687?

NCT03339687 is sponsored by University of Konstanz.

What drugs are being tested in NCT03339687?

Interventions in NCT03339687: Experimental Mindset Induction.

What condition does NCT03339687 study?

NCT03339687 studies Alcohol Drinking.

Is NCT03339687 still recruiting?

NCT03339687 is currently completed. Last updated 19 April 2021.

Last reviewed 2021-04-19 · How we verify

NCT03339687

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Addiction Risk: The Influence of Mindset Induction on the Effect of a Brief Intervention to Reduce Alcohol Use

Completed NA Last updated 19 April 2021

What this trial tests

NA trial testing Experimental Mindset Induction in Alcohol Drinking in 66 participants. Completed in 31 December 2020.

Timeline

11 May 2017

Primary endpoint
31 October 2020

31 December 2020

Quick facts

Lead sponsor	University of Konstanz
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	66
Start date	11 May 2017
Primary completion	31 October 2020
Estimated completion	31 December 2020
Sites	1 location across Germany

Drugs / interventions tested

Experimental Mindset Induction

Conditions studied

Alcohol Drinking — all drugs for Alcohol Drinking →

Sponsor

University of Konstanz

Who can join

18 and older, any sex, with Alcohol Drinking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brief Interventions (BI) based on Motivational Interviewing are effective to reduce alcohol use. In this study the investigators test the hypothesis that that an open Mindset increases the positive effects of BI. Patients who are newly admitted to the psychotherapy outpatient clinic are routinely screened for risky alcohol use. All patients with risky alcohol use are eligible to the study and all receive the WHO's ASSIST-linked BI. Participants receive a brief Mindset induction prior to receiving BI. They are are randomly assigned to either the induction of an open or a closed Mindset according to Gollwitzer. The investigators measure the change in alcohol-related risk perception, treatment motivation and real alcohol drinking.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Alcohol Drinking

Currently open trials in the same condition.

NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
NCT06994962 — Multi-Component Breath Alcohol Intervention Phase 3 · NA · recruiting
NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group · NA · recruiting
NCT06309134 — The Healthy Families Bright Futures Program · NA · recruiting

Other University of Konstanz trials

Trials by the same sponsor.

NCT05167097 — Mindsets and the Effectiveness of a Brief Intervention - Replication · NA · completed
NCT04985786 — Dynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and Schizophrenia · NA · unknown
NCT04832035 — Integration of Refugees Into Public Mental Health Care · NA · unknown
NCT05136105 — Preventing Trauma Symptoms in the Aftermath of Sexual Abuse in Children and Adolescents in Burundi · NA · completed
NCT04061954 — Umuryango Ukomera Uri Hamwe - Families Are Strong Together · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03339687 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Konstanz
Last refreshed: 19 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03339687.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing